Senseonics Holdings, Inc. shareholders approved Approval of the Senseonics Holdings, Inc. 2026 Equity Incentive Plan..
“Proposal No. 6 : Approval of the Senseonics Holdings, Inc. 2026 Equity Incentive Plan: Votes For Votes Against Abstained Broker Non- Votes Approval of the Senseonics Holdings, Inc. 2026 Equity Incentive Plan 10,458,422 2,307,794 194,538 10,689,485”
Shareholder Votes
Senseonics Holdings, Inc. shareholders approved Approval of an amendment to the Company’s amended and restated certificate of incorporation to increase the authorized number of shares of common stock from 70,000,000 to 140,000,000 shares..
“Proposal No. 5 : Approval of an amendment to the Company’s amended and restated certificate of incorporation to increase the authorized number of shares of common stock from 70,000,000 to 140,000,000 shares (the “ Amendment ”): Votes For Votes Against Abstained Approval of an amendment to the Company's amended and restated certificate of incorporation 15,735,743 6,871,884 1,042,612”
Shareholder Votes
Senseonics Holdings, Inc. shareholders approved Ratification of the appointment of KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-12-31 meeting.
“Proposal No. 4 : Ratification of the appointment of KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. The votes were cast as follows: Votes For Votes Against Abstained Ratification of appointment of KPMG LLP 21,085,578 2,185,666 378,995”
Shareholder Votes
Senseonics Holdings, Inc. shareholders approved Approval of the frequency of advisory votes on the compensation of the Company’s named executive officers..
“Proposal No. 3 : Approval of the frequency of advisory votes on the compensation of the Company’s named executive officers. The votes were cast as follows: One Year Two Years Three Years Abstained Broker Non- Votes Frequency of advisory votes on compensation of the Company’s named executive officers 10,790,815 160,133 994,902 1,014,904 10,689,485”
Shareholder Votes
Senseonics Holdings, Inc. shareholders approved Approval, on an advisory basis, of the compensation paid to the Company’s Named Executive Officers..
“Proposal No. 2 : Approval, on an advisory basis, of the compensation paid to the Company’s Named Executive Officers, as described in the proxy statement. The votes were cast as follows: Votes For Votes Against Abstained Broker Non- Votes Approval, on an advisory basis, of the compensation paid to the named executive officers 10,358,401 2,379,720 222,633 10,689,485”
Shareholder Votes
Senseonics Holdings, Inc. shareholders approved Election of three nominees to serve as directors until the 2029 annual meeting of stockholders..
“Proposal No. 1 : Election of three nominees to serve as directors until the 2029 annual meeting of stockholders and until their respective successors are elected and qualified. The votes were cast as follows: Name Votes For Votes Withheld Broker Non-Votes Timothy T. Goodnow 10,737,689 2,223,065 10,689,485 Francine R. Kaufman 10,995,083 1,965,671 10,689,485 Sharon Larkin 10,883,177 2,077,577 10,689,485 All nominees were elected.”
Governance Changes
Senseonics Holdings, Inc.: Increased authorized shares of common stock from 70,000,000 to 140,000,000 (effective 2026-05-20).
“the Company filed the Amendment with the Secretary of State of the State of Delaware.”
Material Agreements
Senseonics Holdings, Inc. amended Second Amendment to Loan and Security Agreement with Hercules Capital, Inc. and the Lenders valued at up to $140.0 million (effective 2026-05-01).
“On May 1, 2026, Senseonics Holdings, Inc. (the “Company”) together with several of its wholly-owned subsidiaries (collectively, “Senseonics”) entered into a Second Amendment to Loan and Security Agreement (the “Second Amendment”) with the several financial institutions or entities party thereto (collectively, the “Lenders”) and Hercules Capital, Inc., a Maryland corporation (the “Agent”), in its capacity as administrative agent and collateral agent for itself and the Lenders, which further amends the Company’s existing Loan and Security Agreement”
Debt Financings
Senseonics Holdings, Inc. incurred term loan of $10.0 million with Hercules Capital, Inc. at the greater of (i) the prime rate as reported in The Wall Street Journal plus 2. maturing September 3, 2029.
“a term loan of $10.0 million to be funded at the closing of the Second Amendment (the “Tranche 2 Loan”)”
Earnings Releases
Senseonics Holdings, Inc. reported the quarter ended March 31, 2026 results: revenue approximately $11.7 million.
“Although the Company has not finalized its full financial results for the quarter ended March 31, 2026, it expects to report the following selected financial information as of and for the quarter ended March 31, 2026: · revenue of approximately $11.7 million; · gross profit of approximately $6.4 million; · gross margin of approximately 54%; · net loss between $31 million and $33 million; · cash, cash equivalents, short-term investments and restricted cash of approximately $64.6 million; · stockholders’ equity of between $33.7 million and $35.7 million.”
Material Agreements
Senseonics Holdings, Inc. entered into Local Asset Purchase Agreements with Ascensia Diabetes Care Holdings AG valued at Cash payment of respective Net Book Value (effective 2026-03-12).
“On March 12, 2026, the Purchaser Parties and the Seller Parties entered into the Local Purchase Agreements, pursuant to which, among other things, the Purchaser Parties agreed to acquire Seller’s and as applicable, Seller Parties’, right, title and interest in and to the European Purchased Assets and to assume the European Assumed Liabilities, as contemplated by the Master Asset Purchase Agreement.”
Material Agreements
Senseonics Holdings, Inc. amended Amended and Restated Collaboration and Commercialization Agreement with Ascensia Diabetes Care Holdings AG (effective 2025-12-31).
“In connection with entering into the Master Asset Purchase Agreement, Senseonics Inc. and the Seller entered into an Amended and Restated Collaboration and Commercialization Agreement (the “ A&R Collaboration Agreement ”) on the Execution Date, which amended and restated that certain Collaboration and Commercialization Agreement, dated August 9, 2020, between Senseonics Inc. and the Seller, as amended to date (the “ Existing Agreement ”).”
Material Agreements
Senseonics Holdings, Inc. entered into Master Asset Purchase Agreement with Ascensia Diabetes Care Holdings AG valued at approximately $1.1 million (effective 2025-12-31).
“On December 31, 2025 (the “ Execution Date ”), Senseonics Holdings, Inc. (the “ Company ”), Senseonics, Incorporated, a wholly-owned subsidiary of the Company (“ Senseonics Inc. ” and together with the Company, the “ Purchaser Parties ”) and Ascensia Diabetes Care Holdings AG (the “ Seller ”) entered into a master asset purchase agreement (the “ Master Asset Purchase Agreement ”), pursuant to which, among other things, the Purchaser Parties agreed to acquire Seller’s and as applicable, Seller’s affiliates’, right, title and interest in and to certain assets related Seller’s marketing, selling and distribution of the Eversense® product in the United States”
Governance Changes
Senseonics Holdings, Inc.: Amended certificate of incorporation to effect 1-for-20 reverse stock split and reduce authorized shares from 1,400,000,000 to 70,000,000 (effective 2025-10-17).
“On October 16, 2025, Senseonics Holdings, Inc. (the “Company”) filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “Amendment”) with the Secretary of State of the State of Delaware to effect the previously disclosed one-for-twenty (1-for-20) reverse stock split (the “Reverse Stock Split”) of its outstanding common stock and a proportional decrease in the total number of authorized shares of its common stock from 1,400,000,000 to 70,000,000 (the “Shares Reduction”).”
Debt Financings
Senseonics Holdings, Inc. amended credit facility of up to $100.0 million in senior secured term loans, consisting of (i) an initial term loan of $35.0 million, which was fu with Hercules Capital, Inc. at annual rate equal to the greater of (i) the prime rate as reported in The Wall S maturing September 3, 2029.
“among the Company, Senseonics Inc., certain of the Lenders and the Agent. Pursuant to the Amended Loan Agreement, the Lenders have agreed to make available to Senseonics up to $100.0 million in senior secured term loans, consisting of (i) an initial term loan of $35.0 million, which was funded on the Effective Date to refinance the outstanding term loans under the”
Anthony Raab resigned as Director at Senseonics Holdings, Inc..
“On January 17, 2025, Anthony Raab, a director of Senseonics Holdings, Inc. (the “Company”) notified the Board of Directors of the Company (the “Board”) of his resignation from the Board effective as of January 17, 2025, in order to focus on his time commitments to his professional investment career, other board roles and family.”
Earnings Releases
Senseonics Holdings, Inc. reported quarter ended March 31, 2024 results: revenue $5.1 million, net income Net loss was $18.9 million, or $0.03 per share, EPS $0.03 per share.
“Total revenue for the first quarter of 2024 was $5.1 million compared to $4.1 million for the first quarter of 2023.”
Brian Hansen was appointed as director at Senseonics Holdings, Inc..
“On March 20, 2024, the Board appointed Brian Hansen to serve as a director of the Company.”
Robert Schumm resigned as director at Senseonics Holdings, Inc..
“On March 19, 2024, Robert Schumm, a director of Senseonics Holdings, Inc. (the “Company”) who was designated to serve as a director of the Company by PHC Holdings Corporation (“PHC”), notified the Board of Directors of the Company (the “Board”) of his resignation from the Board effective March 19, 2024.”
Earnings Releases
Senseonics Holdings, Inc. reported the quarter and year ended December 31, 2023 results: revenue $22.4 million, net income Net loss was $60.4 million, EPS $0.11 per share.
“Total revenue for the fourth quarter of 2023 was $8.0 million compared to $5.6 million for the fourth quarter of 2022.”
Debt Financings
Senseonics Holdings, Inc. incurred term loan of $10.0 million with Hercules Capital, Inc..
“On January 2, 2024, the Tranche 2 Loan was funded in an amount of $10.0 million following the Company’s satisfaction of certain terms and conditions set forth in the Loan Agreement in the fourth quarter of 2023.”
Earnings Releases
Senseonics Holdings, Inc. reported full year 2023 results: revenue $20 million to $24 million. Guidance reaffirmed.
“Senseonics expects full year 2023 global net revenue to be at the midpoint of the $20 million to $24 million range.”
Earnings Releases
Senseonics Holdings, Inc. reported third quarter of 2023 results: revenue $6.1 million, net income Net loss was $24.1 million, or $0.04 per share, EPS $0.04 per share.
“Total revenue for the third quarter of 2023 was $6.1 million compared to $4.6 million for the third quarter of 2022.”
Debt Financings
Senseonics Holdings, Inc. incurred term loan of up to $50.0 million with Hercules Capital, Inc. at greater of (i) the prime rate as reported in The Wall Street Journal plus 1.40% maturing September 1, 2027.
“pursuant to which the Lenders have agreed to make available to Senseonics up to $50.0 million in senior secured term loans”
Material Agreements
Senseonics Holdings, Inc. entered into Loan Agreement with Hercules Capital, Inc. and several financial institutions valued at up to $50.0 million (effective 2023-09-08).
“On September 8, 2023 (the “Effective Date”), Senseonics Holdings, Inc. (the “Company”) and Senseonics, Incorporated, a wholly-owned subsidiary of the Company (together with the Company, “Senseonics”) entered into a Loan and Security Agreement (the “Loan Agreement”) with the several financial institutions or entities party thereto (collectively, the “Lenders”) and Hercules Capital, Inc., a Maryland corporation (“Hercules”), in its capacity as administrative agent and collateral agent for itself and the Lenders, pursuant to which the Lenders have agreed to make available to Senseonics up to $50.0 million in senior secured term loans”
Earnings Releases
Senseonics Holdings, Inc. reported full year 2023 results: revenue $20 million to $24 million. Guidance reaffirmed.
“Senseonics reiterates the expectation for full year 2023 global net revenue to be in the range of $20 million to $24 million.”
Earnings Releases
Senseonics Holdings, Inc. reported the quarter ended June 30, 2023 results: revenue $4.1 million, net income $20.4 million, EPS $0.04 per share. Guidance reaffirmed.
“Total revenue for the second quarter of 2023 was $4.1 million compared to $3.7 million for the second quarter of 2022.”
Shareholder Votes
Senseonics Holdings, Inc. shareholders approved Ratification of the appointment of KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2023. at the 2023-05-17 meeting.
“Proposal No. 3 : Ratification of the appointment of KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2023. The votes were cast as follows: Votes For Votes Against Abstained Ratification of appointment of KPMG LLP 249,565,616 16,854,041 2,062,788”
Shareholder Votes
Senseonics Holdings, Inc. shareholders approved Approval, on an advisory basis, of the compensation paid to the Company’s Named Executive Officers, as described in the proxy statement. at the 2023-05-17 meeting.
“Proposal No. 2 : Approval, on an advisory basis, of the compensation paid to the Company’s Named Executive Officers, as described in the proxy statement. The votes were cast as follows: Votes For Votes Against Abstained Broker Non- Votes Approval, on an advisory basis, of the compensation paid to the named executive officers 84,135,004 21,916,745 1,435,716 160,994,980”
Shareholder Votes
Senseonics Holdings, Inc. shareholders approved Election of five nominees to serve as directors until the 2026 annual meeting of stockholders and until their respective successors are elected and qualified. at the 2023-05-17 meeting.
“Proposal No. 1 : Election of five nominees to serve as directors until the 2026 annual meeting of stockholders and until their respective successors are elected and qualified. The votes were cast as follows: Name Votes For Votes Withheld Broker Non-Votes Timothy T. Goodnow 89,286,112 18,201,353 160,994,980 Francine R. Kaufman 87,272,318 20,215,147 160,994,980 Sharon Larkin 86,279,199 21,208,266 160,994,980 Koichiro Sato 91,965,767 15,521,698 160,994,980 Robert Schumm 85,013,338 22,474,127 160,994,980 All nominees were elected.”
Earnings Releases
Senseonics Holdings, Inc. updated its the quarter ended March 31, 2023 guidance (reaffirmed).
“On May 9, 2023, Senseonics Holdings, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2023, as well as information regarding a conference call to discuss these financial results and the Company’s recent corporate highlights and outlook.”
Material Agreements
Senseonics Holdings, Inc. entered into Registration Rights Agreement with PHC Holdings Corporation valued at not specified (effective 2023-03-13).
“In connection with the entry into the Securities Purchase Agreement and the Exchange Agreement, the Company and PHC also entered into a registration rights agreement (the “Registration Rights Agreement”), pursuant to which the Company has agreed to register the resale of the Exchange Warrant Shares and the Purchase Warrant Shares (collectively, the “Warrant Shares”), pursuant to a registration statement on Form S-3 (the “Registration Statement”) to be filed with the U.S. Securities and Exchange Commission (the “SEC”).”
Material Agreements
Senseonics Holdings, Inc. entered into Exchange Agreement with PHC Holdings Corporation valued at $35.0 million aggregate principal amount (effective 2023-03-13).
“Also on March 13, 2023, the Company entered into an Exchange Agreement (the “Exchange Agreement”) with PHC, pursuant to which PHC has agreed to exchange (the “Exchange”) its $35.0 million aggregate principal amount of the Company’s senior secured convertible notes due October 31, 2024 issued on August 9, 2020 (the “PHC Notes”), including all accrued and unpaid interest thereon, for an additional warrant (the “Exchange Warrant”) to purchase up to 68,525,311 shares of the Company’s common stock, $0.001 par value per share (the “Exchange Warrant Shares”).”
Material Agreements
Senseonics Holdings, Inc. entered into Securities Purchase Agreement with PHC Holdings Corporation valued at aggregate gross proceeds of $15.0 million (effective 2023-03-13).
“On March 13, 2023, Senseonics Holdings, Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with PHC Holdings Corporation (“PHC”), pursuant to which the Company issued and sold to PHC in a private placement (the “Private Placement”) a warrant (the “Purchase Warrant”) to purchase an aggregate of 15,425,750 shares of the Company’s common stock, $0.001 par value per share (the “Purchase Warrant Shares”).”
Earnings Releases
Senseonics Holdings, Inc. reported the quarter and full year ended December 31, 2022 results: revenue total revenue for the fourth quarter of 2022 was $5.6 million, net income Net income was $11.6 million, or $.02 per share, in the fourth quarter of 2022, EPS $.02 per share. Guidance reaffirmed.
“total revenue for the fourth quarter of 2022 was $5.6 million”
Earnings Releases
Senseonics Holdings, Inc. reported the quarter ended September 30, 2022 results: revenue $4.6 million, net income $60.4 million, or ($0.13) per share, EPS ($0.13) per share. Guidance lowered.
“sensor. ● Received positive coverage decisions from Blue Cross Blue Shield of Florida and others, adding 5 million covered lives for Eversense E3 CGM. ● Generated revenue of $4.6 million in the third quarter of 2022. “Having launched the partnership with the Nurse Practitioner Group to expand access with in-home and in-office insertion options, we continue to”
Frederick ("Rick") Sullivan was appointed as Chief Financial Officer at Senseonics Holdings, Inc..
“Effective September 1, 2022 (the “ Effective Date ”), the Board of Directors of the Company (the “ Board ”) appointed Frederick (“ Rick”) Sullivan as the Company’s Chief Financial Officer (in which capacity he will serve as the Company’s principal financial officer and principal accounting officer).”
Nicholas B. Tressler changed role as Chief Financial Officer at Senseonics Holdings, Inc..
“On August 30, 2022, Nicholas B. Tressler and Senseonics Holdings, Inc. (the “ Company ”) mutually agreed that Mr. Tressler would transition from his role as the Company’s Chief Financial Officer effective as of September 1, 2022.”
Sharon Larkin was appointed as director at Senseonics Holdings, Inc..
“On December 8, 2021, the board of directors (the “Board”) of Senseonics Holdings, Inc. (the “Company”) appointed Sharon Larkin to serve as a director of the Company, which appointment became effective immediately.”
John Marotta was appointed as Director at Senseonics Holdings, Inc..
“appointed John Marotta to serve as a director of the Company, which appointment became effective immediately.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.